These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9857058)
1. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway. Chen E; Hrdlickova R; Nehyba J; Longo DL; Bose HR; Li CC J Biol Chem; 1998 Dec; 273(52):35201-7. PubMed ID: 9857058 [TBL] [Abstract][Full Text] [Related]
2. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells. Shumway SD; Miyamoto S Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901 [TBL] [Abstract][Full Text] [Related]
3. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Palombella VJ; Rando OJ; Goldberg AL; Maniatis T Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845 [TBL] [Abstract][Full Text] [Related]
4. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848 [TBL] [Abstract][Full Text] [Related]
5. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor. Maggirwar SB; Harhaj E; Sun SC Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Fiedler MA; Wernke-Dollries K; Stark JM Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598 [TBL] [Abstract][Full Text] [Related]
7. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Gregory MA; Hann SR Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166 [TBL] [Abstract][Full Text] [Related]
8. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Scherer DC; Brockman JA; Chen Z; Maniatis T; Ballard DW Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11259-63. PubMed ID: 7479976 [TBL] [Abstract][Full Text] [Related]
9. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Li B; Dou QP Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3850-5. PubMed ID: 10725400 [TBL] [Abstract][Full Text] [Related]
10. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. Krappmann D; Wulczyn FG; Scheidereit C EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567 [TBL] [Abstract][Full Text] [Related]
12. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. O'Connor S; Shumway SD; Amanna IJ; Hayes CE; Miyamoto S Mol Cell Biol; 2004 Jun; 24(11):4895-908. PubMed ID: 15143182 [TBL] [Abstract][Full Text] [Related]
13. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Palombella VJ; Conner EM; Fuseler JW; Destree A; Davis JM; Laroux FS; Wolf RE; Huang J; Brand S; Elliott PJ; Lazarus D; McCormack T; Parent L; Stein R; Adams J; Grisham MB Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15671-6. PubMed ID: 9861028 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis. Milligan SA; Owens MW; Grisham MB Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937 [TBL] [Abstract][Full Text] [Related]
15. Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta. Good L; Sun SC J Virol; 1996 May; 70(5):2730-5. PubMed ID: 8627746 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830 [TBL] [Abstract][Full Text] [Related]
17. Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product. Chu ZL; McKinsey TA; Liu L; Qi X; Ballard DW Mol Cell Biol; 1996 Nov; 16(11):5974-84. PubMed ID: 8887627 [TBL] [Abstract][Full Text] [Related]
18. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability. Nakagawa K; Yokosawa H Eur J Biochem; 2000 Mar; 267(6):1680-6. PubMed ID: 10712599 [TBL] [Abstract][Full Text] [Related]
19. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142 [TBL] [Abstract][Full Text] [Related]
20. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum. Qin Z; Wang Y; Chasea TN Brain Res Mol Brain Res; 2000 Sep; 80(2):111-22. PubMed ID: 11038244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]